nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—liver cancer	0.575	1	CbGaD
Mirabegron—ABCB1—Sorafenib—liver cancer	0.037	0.245	CbGbCtD
Mirabegron—CYP2D6—Sorafenib—liver cancer	0.0349	0.231	CbGbCtD
Mirabegron—ABCB1—Doxorubicin—liver cancer	0.0225	0.149	CbGbCtD
Mirabegron—CYP3A4—Sorafenib—liver cancer	0.0222	0.147	CbGbCtD
Mirabegron—CYP2D6—Doxorubicin—liver cancer	0.0212	0.14	CbGbCtD
Mirabegron—ORM1—bile—liver cancer	0.0191	0.348	CbGeAlD
Mirabegron—BCHE—diaphragm—liver cancer	0.0179	0.325	CbGeAlD
Mirabegron—CYP3A4—Doxorubicin—liver cancer	0.0135	0.089	CbGbCtD
Mirabegron—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.00671	0.0484	CcSEcCtD
Mirabegron—ORM1—gall bladder—liver cancer	0.00531	0.0966	CbGeAlD
Mirabegron—ALB—gall bladder—liver cancer	0.00466	0.0847	CbGeAlD
Mirabegron—Blood pressure increased—Sorafenib—liver cancer	0.00329	0.0237	CcSEcCtD
Mirabegron—Rash papular—Epirubicin—liver cancer	0.00327	0.0235	CcSEcCtD
Mirabegron—Rash papular—Doxorubicin—liver cancer	0.00302	0.0218	CcSEcCtD
Mirabegron—Neoplasm—Sorafenib—liver cancer	0.00298	0.0215	CcSEcCtD
Mirabegron—Lactic dehydrogenase activity increased—Epirubicin—liver cancer	0.00238	0.0171	CcSEcCtD
Mirabegron—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.0022	0.0159	CcSEcCtD
Mirabegron—Breast disorder—Sorafenib—liver cancer	0.00216	0.0156	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00215	0.0155	CcSEcCtD
Mirabegron—Nasopharyngitis—Sorafenib—liver cancer	0.00214	0.0154	CcSEcCtD
Mirabegron—Gastritis—Sorafenib—liver cancer	0.00211	0.0152	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00211	0.0152	CcSEcCtD
Mirabegron—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.00209	0.0151	CcSEcCtD
Mirabegron—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.00194	0.014	CcSEcCtD
Mirabegron—Infestation NOS—Sorafenib—liver cancer	0.00184	0.0133	CcSEcCtD
Mirabegron—Infestation—Sorafenib—liver cancer	0.00184	0.0133	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00183	0.0132	CcSEcCtD
Mirabegron—Urinary tract disorder—Sorafenib—liver cancer	0.00163	0.0118	CcSEcCtD
Mirabegron—Connective tissue disorder—Sorafenib—liver cancer	0.00162	0.0117	CcSEcCtD
Mirabegron—Urethral disorder—Sorafenib—liver cancer	0.00162	0.0117	CcSEcCtD
Mirabegron—Erythema multiforme—Sorafenib—liver cancer	0.00156	0.0113	CcSEcCtD
Mirabegron—ORM1—liver—liver cancer	0.00156	0.0283	CbGeAlD
Mirabegron—Cardiac disorder—Sorafenib—liver cancer	0.00153	0.0111	CcSEcCtD
Mirabegron—SLCO1A2—liver—liver cancer	0.00137	0.025	CbGeAlD
Mirabegron—ALB—liver—liver cancer	0.00137	0.0248	CbGeAlD
Mirabegron—Hypertension—Sorafenib—liver cancer	0.00124	0.00896	CcSEcCtD
Mirabegron—Arthralgia—Sorafenib—liver cancer	0.00123	0.00883	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00122	0.00877	CcSEcCtD
Mirabegron—Dry mouth—Sorafenib—liver cancer	0.0012	0.00864	CcSEcCtD
Mirabegron—Cystitis noninfective—Epirubicin—liver cancer	0.00119	0.00857	CcSEcCtD
Mirabegron—Cystitis—Epirubicin—liver cancer	0.00117	0.00847	CcSEcCtD
Mirabegron—Infection—Sorafenib—liver cancer	0.00117	0.00841	CcSEcCtD
Mirabegron—Vaginal infection—Epirubicin—liver cancer	0.00115	0.00828	CcSEcCtD
Mirabegron—Skin disorder—Sorafenib—liver cancer	0.00114	0.00822	CcSEcCtD
Mirabegron—Dry eye—Epirubicin—liver cancer	0.00112	0.0081	CcSEcCtD
Mirabegron—Neoplasm—Epirubicin—liver cancer	0.0011	0.00793	CcSEcCtD
Mirabegron—Bladder pain—Epirubicin—liver cancer	0.0011	0.00793	CcSEcCtD
Mirabegron—Cystitis noninfective—Doxorubicin—liver cancer	0.0011	0.00793	CcSEcCtD
Mirabegron—Cystitis—Doxorubicin—liver cancer	0.00109	0.00784	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00107	0.00771	CcSEcCtD
Mirabegron—Vaginal infection—Doxorubicin—liver cancer	0.00106	0.00766	CcSEcCtD
Mirabegron—Dry eye—Doxorubicin—liver cancer	0.00104	0.00749	CcSEcCtD
Mirabegron—Dyspepsia—Sorafenib—liver cancer	0.00103	0.00745	CcSEcCtD
Mirabegron—Neoplasm—Doxorubicin—liver cancer	0.00102	0.00734	CcSEcCtD
Mirabegron—Bladder pain—Doxorubicin—liver cancer	0.00102	0.00734	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Sorafenib—liver cancer	0.00101	0.00731	CcSEcCtD
Mirabegron—Fatigue—Sorafenib—liver cancer	0.00101	0.0073	CcSEcCtD
Mirabegron—Constipation—Sorafenib—liver cancer	0.001	0.00724	CcSEcCtD
Mirabegron—ABCB1—embryo—liver cancer	0.000996	0.0181	CbGeAlD
Mirabegron—Vascular purpura—Epirubicin—liver cancer	0.000987	0.00712	CcSEcCtD
Mirabegron—BCHE—liver—liver cancer	0.000966	0.0176	CbGeAlD
Mirabegron—Gastrointestinal pain—Sorafenib—liver cancer	0.00096	0.00692	CcSEcCtD
Mirabegron—Urticaria—Sorafenib—liver cancer	0.000933	0.00673	CcSEcCtD
Mirabegron—Abdominal pain—Sorafenib—liver cancer	0.000929	0.00669	CcSEcCtD
Mirabegron—Purpura—Epirubicin—liver cancer	0.000916	0.0066	CcSEcCtD
Mirabegron—Vascular purpura—Doxorubicin—liver cancer	0.000913	0.00658	CcSEcCtD
Mirabegron—Cerebrovascular accident—Epirubicin—liver cancer	0.000901	0.0065	CcSEcCtD
Mirabegron—Osteoarthritis—Epirubicin—liver cancer	0.000883	0.00637	CcSEcCtD
Mirabegron—Purpura—Doxorubicin—liver cancer	0.000848	0.00611	CcSEcCtD
Mirabegron—Asthenia—Sorafenib—liver cancer	0.000843	0.00607	CcSEcCtD
Mirabegron—Cerebrovascular accident—Doxorubicin—liver cancer	0.000834	0.00601	CcSEcCtD
Mirabegron—Pruritus—Sorafenib—liver cancer	0.000831	0.00599	CcSEcCtD
Mirabegron—Osteoarthritis—Doxorubicin—liver cancer	0.000817	0.00589	CcSEcCtD
Mirabegron—Diarrhoea—Sorafenib—liver cancer	0.000804	0.00579	CcSEcCtD
Mirabegron—Breast disorder—Epirubicin—liver cancer	0.000798	0.00575	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000795	0.00573	CcSEcCtD
Mirabegron—Nasopharyngitis—Epirubicin—liver cancer	0.00079	0.00569	CcSEcCtD
Mirabegron—Gastritis—Epirubicin—liver cancer	0.000782	0.00563	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000779	0.00561	CcSEcCtD
Mirabegron—Dizziness—Sorafenib—liver cancer	0.000777	0.0056	CcSEcCtD
Mirabegron—Abdominal distension—Epirubicin—liver cancer	0.000768	0.00554	CcSEcCtD
Mirabegron—Influenza—Epirubicin—liver cancer	0.000763	0.0055	CcSEcCtD
Mirabegron—Rash—Sorafenib—liver cancer	0.000741	0.00534	CcSEcCtD
Mirabegron—Dermatitis—Sorafenib—liver cancer	0.00074	0.00533	CcSEcCtD
Mirabegron—Breast disorder—Doxorubicin—liver cancer	0.000738	0.00532	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000736	0.0053	CcSEcCtD
Mirabegron—Headache—Sorafenib—liver cancer	0.000736	0.0053	CcSEcCtD
Mirabegron—Nasopharyngitis—Doxorubicin—liver cancer	0.000731	0.00527	CcSEcCtD
Mirabegron—Gastritis—Doxorubicin—liver cancer	0.000723	0.00521	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000721	0.00519	CcSEcCtD
Mirabegron—Abdominal distension—Doxorubicin—liver cancer	0.000711	0.00513	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Epirubicin—liver cancer	0.000709	0.00511	CcSEcCtD
Mirabegron—Influenza—Doxorubicin—liver cancer	0.000706	0.00509	CcSEcCtD
Mirabegron—Nausea—Sorafenib—liver cancer	0.000698	0.00503	CcSEcCtD
Mirabegron—Infestation NOS—Epirubicin—liver cancer	0.000681	0.00491	CcSEcCtD
Mirabegron—Infestation—Epirubicin—liver cancer	0.000681	0.00491	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000675	0.00486	CcSEcCtD
Mirabegron—Urinary tract infection—Epirubicin—liver cancer	0.000662	0.00477	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000656	0.00473	CcSEcCtD
Mirabegron—CYP3A4—liver—liver cancer	0.00065	0.0118	CbGeAlD
Mirabegron—CYP2D6—liver—liver cancer	0.00064	0.0116	CbGeAlD
Mirabegron—Sinusitis—Epirubicin—liver cancer	0.000639	0.0046	CcSEcCtD
Mirabegron—Infestation NOS—Doxorubicin—liver cancer	0.00063	0.00454	CcSEcCtD
Mirabegron—Infestation—Doxorubicin—liver cancer	0.00063	0.00454	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000624	0.0045	CcSEcCtD
Mirabegron—Rhinitis—Epirubicin—liver cancer	0.000613	0.00442	CcSEcCtD
Mirabegron—Urinary tract infection—Doxorubicin—liver cancer	0.000612	0.00441	CcSEcCtD
Mirabegron—Urinary tract disorder—Epirubicin—liver cancer	0.000603	0.00435	CcSEcCtD
Mirabegron—Connective tissue disorder—Epirubicin—liver cancer	0.0006	0.00433	CcSEcCtD
Mirabegron—Urethral disorder—Epirubicin—liver cancer	0.000599	0.00432	CcSEcCtD
Mirabegron—Sinusitis—Doxorubicin—liver cancer	0.000591	0.00426	CcSEcCtD
Mirabegron—Erythema multiforme—Epirubicin—liver cancer	0.000578	0.00416	CcSEcCtD
Mirabegron—Eye disorder—Epirubicin—liver cancer	0.000571	0.00412	CcSEcCtD
Mirabegron—Cardiac disorder—Epirubicin—liver cancer	0.000567	0.00409	CcSEcCtD
Mirabegron—Rhinitis—Doxorubicin—liver cancer	0.000567	0.00409	CcSEcCtD
Mirabegron—Urinary tract disorder—Doxorubicin—liver cancer	0.000558	0.00402	CcSEcCtD
Mirabegron—Connective tissue disorder—Doxorubicin—liver cancer	0.000556	0.004	CcSEcCtD
Mirabegron—Urethral disorder—Doxorubicin—liver cancer	0.000554	0.00399	CcSEcCtD
Mirabegron—Erythema multiforme—Doxorubicin—liver cancer	0.000535	0.00385	CcSEcCtD
Mirabegron—Eye disorder—Doxorubicin—liver cancer	0.000528	0.00381	CcSEcCtD
Mirabegron—Cardiac disorder—Doxorubicin—liver cancer	0.000525	0.00378	CcSEcCtD
Mirabegron—Back pain—Epirubicin—liver cancer	0.000514	0.00371	CcSEcCtD
Mirabegron—Vision blurred—Epirubicin—liver cancer	0.000501	0.00361	CcSEcCtD
Mirabegron—Back pain—Doxorubicin—liver cancer	0.000476	0.00343	CcSEcCtD
Mirabegron—Palpitations—Epirubicin—liver cancer	0.00047	0.00339	CcSEcCtD
Mirabegron—Vision blurred—Doxorubicin—liver cancer	0.000464	0.00334	CcSEcCtD
Mirabegron—ABCB1—liver—liver cancer	0.00046	0.00837	CbGeAlD
Mirabegron—Hypertension—Epirubicin—liver cancer	0.000459	0.00331	CcSEcCtD
Mirabegron—Arthralgia—Epirubicin—liver cancer	0.000453	0.00326	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00045	0.00324	CcSEcCtD
Mirabegron—Dry mouth—Epirubicin—liver cancer	0.000443	0.00319	CcSEcCtD
Mirabegron—Palpitations—Doxorubicin—liver cancer	0.000435	0.00313	CcSEcCtD
Mirabegron—Infection—Epirubicin—liver cancer	0.000431	0.00311	CcSEcCtD
Mirabegron—Hypertension—Doxorubicin—liver cancer	0.000425	0.00306	CcSEcCtD
Mirabegron—Tachycardia—Epirubicin—liver cancer	0.000424	0.00305	CcSEcCtD
Mirabegron—Skin disorder—Epirubicin—liver cancer	0.000422	0.00304	CcSEcCtD
Mirabegron—Arthralgia—Doxorubicin—liver cancer	0.000419	0.00302	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000416	0.003	CcSEcCtD
Mirabegron—Dry mouth—Doxorubicin—liver cancer	0.00041	0.00295	CcSEcCtD
Mirabegron—Infection—Doxorubicin—liver cancer	0.000399	0.00288	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000395	0.00285	CcSEcCtD
Mirabegron—Tachycardia—Doxorubicin—liver cancer	0.000392	0.00283	CcSEcCtD
Mirabegron—Skin disorder—Doxorubicin—liver cancer	0.00039	0.00281	CcSEcCtD
Mirabegron—Dyspepsia—Epirubicin—liver cancer	0.000382	0.00275	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Epirubicin—liver cancer	0.000375	0.0027	CcSEcCtD
Mirabegron—Fatigue—Epirubicin—liver cancer	0.000374	0.0027	CcSEcCtD
Mirabegron—Constipation—Epirubicin—liver cancer	0.000371	0.00268	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000366	0.00264	CcSEcCtD
Mirabegron—Gastrointestinal pain—Epirubicin—liver cancer	0.000355	0.00256	CcSEcCtD
Mirabegron—Dyspepsia—Doxorubicin—liver cancer	0.000354	0.00255	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000347	0.0025	CcSEcCtD
Mirabegron—Fatigue—Doxorubicin—liver cancer	0.000346	0.0025	CcSEcCtD
Mirabegron—Urticaria—Epirubicin—liver cancer	0.000345	0.00249	CcSEcCtD
Mirabegron—Constipation—Doxorubicin—liver cancer	0.000343	0.00248	CcSEcCtD
Mirabegron—Abdominal pain—Epirubicin—liver cancer	0.000343	0.00247	CcSEcCtD
Mirabegron—Gastrointestinal pain—Doxorubicin—liver cancer	0.000328	0.00237	CcSEcCtD
Mirabegron—Urticaria—Doxorubicin—liver cancer	0.000319	0.0023	CcSEcCtD
Mirabegron—Abdominal pain—Doxorubicin—liver cancer	0.000318	0.00229	CcSEcCtD
Mirabegron—Asthenia—Epirubicin—liver cancer	0.000311	0.00224	CcSEcCtD
Mirabegron—Pruritus—Epirubicin—liver cancer	0.000307	0.00221	CcSEcCtD
Mirabegron—Diarrhoea—Epirubicin—liver cancer	0.000297	0.00214	CcSEcCtD
Mirabegron—Asthenia—Doxorubicin—liver cancer	0.000288	0.00208	CcSEcCtD
Mirabegron—Dizziness—Epirubicin—liver cancer	0.000287	0.00207	CcSEcCtD
Mirabegron—Pruritus—Doxorubicin—liver cancer	0.000284	0.00205	CcSEcCtD
Mirabegron—Diarrhoea—Doxorubicin—liver cancer	0.000275	0.00198	CcSEcCtD
Mirabegron—Rash—Epirubicin—liver cancer	0.000274	0.00197	CcSEcCtD
Mirabegron—Dermatitis—Epirubicin—liver cancer	0.000273	0.00197	CcSEcCtD
Mirabegron—Headache—Epirubicin—liver cancer	0.000272	0.00196	CcSEcCtD
Mirabegron—Dizziness—Doxorubicin—liver cancer	0.000266	0.00191	CcSEcCtD
Mirabegron—Nausea—Epirubicin—liver cancer	0.000258	0.00186	CcSEcCtD
Mirabegron—Rash—Doxorubicin—liver cancer	0.000253	0.00183	CcSEcCtD
Mirabegron—Dermatitis—Doxorubicin—liver cancer	0.000253	0.00182	CcSEcCtD
Mirabegron—Headache—Doxorubicin—liver cancer	0.000252	0.00181	CcSEcCtD
Mirabegron—Nausea—Doxorubicin—liver cancer	0.000239	0.00172	CcSEcCtD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	3.77e-05	0.000468	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTA3—liver cancer	3.75e-05	0.000466	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	3.74e-05	0.000465	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP2E1—liver cancer	3.73e-05	0.000463	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CSF2—liver cancer	3.7e-05	0.000459	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—RAF1—liver cancer	3.69e-05	0.000458	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.66e-05	0.000454	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—H2AFX—liver cancer	3.64e-05	0.000452	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—IL2—liver cancer	3.64e-05	0.000452	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.64e-05	0.000452	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.61e-05	0.000449	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—MMP2—liver cancer	3.61e-05	0.000448	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	3.61e-05	0.000448	CbGpPWpGaD
Mirabegron—BCHE—Neuronal System—HRAS—liver cancer	3.6e-05	0.000447	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CB—liver cancer	3.6e-05	0.000447	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	3.57e-05	0.000443	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—UGDH—liver cancer	3.53e-05	0.000438	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTP1—liver cancer	3.51e-05	0.000435	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYCS—liver cancer	3.49e-05	0.000433	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CPT1B—liver cancer	3.47e-05	0.00043	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GLUL—liver cancer	3.47e-05	0.00043	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—HMOX1—liver cancer	3.46e-05	0.000429	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTA4—liver cancer	3.43e-05	0.000426	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GGT1—liver cancer	3.43e-05	0.000425	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GOT1—liver cancer	3.43e-05	0.000425	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.35e-05	0.000416	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	3.35e-05	0.000415	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTA2—liver cancer	3.34e-05	0.000415	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NR1H4—liver cancer	3.34e-05	0.000415	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—EPT1—liver cancer	3.31e-05	0.000411	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL2—liver cancer	3.31e-05	0.000411	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TERT—liver cancer	3.3e-05	0.000409	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.3e-05	0.000409	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTA3—liver cancer	3.29e-05	0.000408	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CPT1B—liver cancer	3.27e-05	0.000405	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GLUL—liver cancer	3.27e-05	0.000405	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTA1—liver cancer	3.23e-05	0.0004	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTM1—liver cancer	3.22e-05	0.0004	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NAT2—liver cancer	3.19e-05	0.000396	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.16e-05	0.000392	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NR1H4—liver cancer	3.15e-05	0.000391	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TAT—liver cancer	3.14e-05	0.00039	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK14—liver cancer	3.11e-05	0.000386	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTA3—liver cancer	3.1e-05	0.000384	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTP1—liver cancer	3.08e-05	0.000382	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	3.07e-05	0.000381	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.07e-05	0.000381	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALDOB—liver cancer	3.06e-05	0.000379	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP1A1—liver cancer	3.06e-05	0.000379	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMOX1—liver cancer	3.04e-05	0.000377	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.03e-05	0.000376	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.02e-05	0.000375	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KDR—liver cancer	3.01e-05	0.000374	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—F2—liver cancer	3.01e-05	0.000374	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTA4—liver cancer	3.01e-05	0.000373	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK14—liver cancer	2.99e-05	0.000372	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ESR1—liver cancer	2.94e-05	0.000365	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTA2—liver cancer	2.93e-05	0.000364	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CRABP1—liver cancer	2.92e-05	0.000362	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.92e-05	0.000362	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—F2—liver cancer	2.9e-05	0.00036	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CG—liver cancer	2.88e-05	0.000358	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—liver cancer	2.85e-05	0.000354	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTA4—liver cancer	2.83e-05	0.000352	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTM1—liver cancer	2.83e-05	0.000351	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTA1—liver cancer	2.83e-05	0.000351	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.82e-05	0.000351	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.8e-05	0.000348	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARA—liver cancer	2.8e-05	0.000347	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NAT2—liver cancer	2.79e-05	0.000347	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APC—liver cancer	2.78e-05	0.000345	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CG—liver cancer	2.78e-05	0.000345	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CTNNB1—liver cancer	2.77e-05	0.000344	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTA2—liver cancer	2.76e-05	0.000343	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP1A1—liver cancer	2.68e-05	0.000333	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDOB—liver cancer	2.68e-05	0.000333	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTA1—liver cancer	2.66e-05	0.000331	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NAT2—liver cancer	2.63e-05	0.000327	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.63e-05	0.000326	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.61e-05	0.000324	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—BRAF—liver cancer	2.61e-05	0.000324	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.57e-05	0.000319	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CRABP1—liver cancer	2.56e-05	0.000317	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.55e-05	0.000317	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HPGDS—liver cancer	2.55e-05	0.000316	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CD—liver cancer	2.54e-05	0.000315	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.53e-05	0.000315	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDOB—liver cancer	2.52e-05	0.000313	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.51e-05	0.000312	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SERPINE1—liver cancer	2.51e-05	0.000311	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—liver cancer	2.5e-05	0.00031	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.49e-05	0.000309	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARA—liver cancer	2.45e-05	0.000304	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CD—liver cancer	2.44e-05	0.000303	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CA—liver cancer	2.42e-05	0.0003	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SERPINE1—liver cancer	2.41e-05	0.0003	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CRABP1—liver cancer	2.41e-05	0.000299	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CG—liver cancer	2.39e-05	0.000297	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—KRAS—liver cancer	2.39e-05	0.000297	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—liver cancer	2.31e-05	0.000287	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.31e-05	0.000287	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSMA4—liver cancer	2.27e-05	0.000282	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PSMD10—liver cancer	2.27e-05	0.000282	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—RAF1—liver cancer	2.26e-05	0.000281	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HPGDS—liver cancer	2.23e-05	0.000277	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GOT2—liver cancer	2.21e-05	0.000274	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CB—liver cancer	2.21e-05	0.000274	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.2e-05	0.000273	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CA—liver cancer	2.2e-05	0.000273	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RAF1—liver cancer	2.18e-05	0.000271	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CPT1B—liver cancer	2.14e-05	0.000265	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GLUL—liver cancer	2.14e-05	0.000265	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	2.14e-05	0.000265	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MTOR—liver cancer	2.13e-05	0.000264	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CB—liver cancer	2.13e-05	0.000264	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HPGDS—liver cancer	2.11e-05	0.000261	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CD—liver cancer	2.1e-05	0.000261	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.1e-05	0.000261	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CG—liver cancer	2.1e-05	0.000261	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2E1—liver cancer	2.08e-05	0.000258	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—liver cancer	2.08e-05	0.000258	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NR1H4—liver cancer	2.06e-05	0.000256	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HRAS—liver cancer	2.03e-05	0.000252	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IL2—liver cancer	2.03e-05	0.000252	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—liver cancer	2.03e-05	0.000252	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA3—liver cancer	2.02e-05	0.000251	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.01e-05	0.00025	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1B—liver cancer	2e-05	0.000248	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSMD10—liver cancer	1.99e-05	0.000247	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PSMA4—liver cancer	1.99e-05	0.000247	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—liver cancer	1.98e-05	0.000245	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.96e-05	0.000243	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CASP3—liver cancer	1.96e-05	0.000243	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL2—liver cancer	1.95e-05	0.000243	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYCS—liver cancer	1.94e-05	0.000241	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—liver cancer	1.94e-05	0.000241	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GOT2—liver cancer	1.94e-05	0.00024	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GGT1—liver cancer	1.91e-05	0.000237	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GOT1—liver cancer	1.91e-05	0.000237	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCND1—liver cancer	1.91e-05	0.000236	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—JUN—liver cancer	1.9e-05	0.000236	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.9e-05	0.000236	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CTNNB1—liver cancer	1.89e-05	0.000234	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSMA4—liver cancer	1.88e-05	0.000233	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PSMD10—liver cancer	1.88e-05	0.000233	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA4—liver cancer	1.85e-05	0.00023	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—liver cancer	1.85e-05	0.00023	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CD—liver cancer	1.85e-05	0.000229	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1A—liver cancer	1.84e-05	0.000229	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CB—liver cancer	1.83e-05	0.000228	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GOT2—liver cancer	1.83e-05	0.000227	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—liver cancer	1.82e-05	0.000226	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2E1—liver cancer	1.82e-05	0.000226	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA2—liver cancer	1.8e-05	0.000224	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK8—liver cancer	1.8e-05	0.000223	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—liver cancer	1.79e-05	0.000223	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTA1—liver cancer	1.74e-05	0.000216	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—liver cancer	1.73e-05	0.000214	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NAT2—liver cancer	1.72e-05	0.000214	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.72e-05	0.000213	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2E1—liver cancer	1.72e-05	0.000213	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTP1—liver cancer	1.71e-05	0.000213	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYCS—liver cancer	1.7e-05	0.000211	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—liver cancer	1.69e-05	0.00021	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GGT1—liver cancer	1.67e-05	0.000208	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GOT1—liver cancer	1.67e-05	0.000208	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—liver cancer	1.66e-05	0.000206	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDOB—liver cancer	1.65e-05	0.000205	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—STAT3—liver cancer	1.64e-05	0.000204	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CB—liver cancer	1.61e-05	0.0002	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYCS—liver cancer	1.61e-05	0.000199	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TGFB1—liver cancer	1.58e-05	0.000197	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GOT1—liver cancer	1.58e-05	0.000196	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GGT1—liver cancer	1.58e-05	0.000196	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTM1—liver cancer	1.58e-05	0.000195	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CRABP1—liver cancer	1.57e-05	0.000195	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MYC—liver cancer	1.53e-05	0.00019	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFB1—liver cancer	1.52e-05	0.000189	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTP1—liver cancer	1.5e-05	0.000186	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP1A1—liver cancer	1.49e-05	0.000185	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—liver cancer	1.48e-05	0.000184	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—KRAS—liver cancer	1.47e-05	0.000182	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTP1—liver cancer	1.42e-05	0.000176	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KRAS—liver cancer	1.41e-05	0.000175	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—liver cancer	1.4e-05	0.000173	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—liver cancer	1.39e-05	0.000173	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTM1—liver cancer	1.38e-05	0.000171	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HPGDS—liver cancer	1.38e-05	0.000171	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARA—liver cancer	1.37e-05	0.00017	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CA—liver cancer	1.35e-05	0.000167	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP1A1—liver cancer	1.31e-05	0.000162	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—liver cancer	1.3e-05	0.000162	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTM1—liver cancer	1.3e-05	0.000161	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CA—liver cancer	1.3e-05	0.000161	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—liver cancer	1.25e-05	0.000156	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—HRAS—liver cancer	1.25e-05	0.000155	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP1A1—liver cancer	1.23e-05	0.000153	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.23e-05	0.000152	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSMA4—liver cancer	1.23e-05	0.000152	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PSMD10—liver cancer	1.23e-05	0.000152	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—liver cancer	1.22e-05	0.000151	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HRAS—liver cancer	1.2e-05	0.000149	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARA—liver cancer	1.2e-05	0.000149	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GOT2—liver cancer	1.19e-05	0.000148	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CG—liver cancer	1.17e-05	0.000145	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—liver cancer	1.15e-05	0.000143	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—liver cancer	1.15e-05	0.000143	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—liver cancer	1.13e-05	0.00014	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARA—liver cancer	1.13e-05	0.00014	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2E1—liver cancer	1.12e-05	0.000139	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CA—liver cancer	1.12e-05	0.000139	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—liver cancer	1.1e-05	0.000137	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—liver cancer	1.06e-05	0.000132	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYCS—liver cancer	1.05e-05	0.00013	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GOT1—liver cancer	1.03e-05	0.000128	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GGT1—liver cancer	1.03e-05	0.000128	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CD—liver cancer	1.03e-05	0.000128	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CG—liver cancer	1.02e-05	0.000127	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—liver cancer	9.89e-06	0.000123	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CA—liver cancer	9.81e-06	0.000122	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CG—liver cancer	9.66e-06	0.00012	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—liver cancer	9.32e-06	0.000116	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTP1—liver cancer	9.25e-06	0.000115	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—liver cancer	9.13e-06	0.000113	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—liver cancer	9.13e-06	0.000113	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CD—liver cancer	9.01e-06	0.000112	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CB—liver cancer	8.96e-06	0.000111	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—liver cancer	8.89e-06	0.00011	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM1—liver cancer	8.5e-06	0.000106	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CD—liver cancer	8.49e-06	0.000105	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—liver cancer	8.38e-06	0.000104	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP1A1—liver cancer	8.06e-06	0.0001	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—liver cancer	8.01e-06	9.95e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CB—liver cancer	7.85e-06	9.75e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—liver cancer	7.51e-06	9.33e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CB—liver cancer	7.4e-06	9.18e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARA—liver cancer	7.37e-06	9.15e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CG—liver cancer	6.31e-06	7.84e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—liver cancer	6.09e-06	7.56e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CD—liver cancer	5.55e-06	6.89e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—liver cancer	5.48e-06	6.8e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CA—liver cancer	5.46e-06	6.78e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CB—liver cancer	4.84e-06	6e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CA—liver cancer	4.79e-06	5.94e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CA—liver cancer	4.51e-06	5.6e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—liver cancer	4.46e-06	5.54e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—liver cancer	3.91e-06	4.85e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—liver cancer	3.68e-06	4.57e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CA—liver cancer	2.95e-06	3.66e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—liver cancer	2.41e-06	2.99e-05	CbGpPWpGaD
